Fujimoto J, Okamoto E, Yamanaka N, Fujiwara S, Kato T, Mitsunobu M, Toyosaka A
First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Nihon Geka Gakkai Zasshi. 1989 Sep;90(9):1568-70.
Retrospective DNA ploidy studies of paraffin-embedded blocks were performed by flow cytometry on 212 surgically resected hepatocellular carcinoma. One hundred and sixty-four of 212 specimens yielded evaluable DNA histograms. Eighty-three cases showed a DNA diploid pattern and 81 a DNA non-diploid pattern. The incidence of non-diploid pattern increased with the tumor size. (2cm; 15.4%, 2-5; 42.3%, 5-10; 70.8% greater than 10; 73.3%). The DNA pattern correlated with the backgrounds, the degree of vascular invasion, intrahepatic metastasis and serum AFP levels. Survival of patients with non-diploid pattern was significantly less than those with diploid patients in any different stage. Of thirty who survived three years with disease free condition, 20 patients showed diploid patterns. Though remaining 10 patients were non-diploid patterns, 9 were high DNA index more than 1.5. It is concluded that flow cytometric DNA ploidy study had prognostic value for patients with surgically resected hepatocellular carcinoma.
对212例手术切除的肝细胞癌石蜡包埋块进行回顾性DNA倍体研究,采用流式细胞术检测。212份标本中有164份获得了可评估的DNA直方图。83例显示DNA二倍体模式,81例显示DNA非二倍体模式。非二倍体模式的发生率随肿瘤大小增加(肿瘤大小2cm时为15.4%,2 - 5cm时为42.3%,5 - 10cm时为70.8%,大于10cm时为73.3%)。DNA模式与肿瘤背景、血管侵犯程度、肝内转移及血清甲胎蛋白水平相关。在任何不同分期中,非二倍体模式患者的生存率均显著低于二倍体模式患者。在30例无病生存3年的患者中,20例显示二倍体模式。其余10例为非二倍体模式,其中9例DNA指数大于1.5。结论是,流式细胞术DNA倍体研究对手术切除的肝细胞癌患者具有预后价值。